DIA

ICR

EntreMed announces changes to board of directors, CEO appointment

Friday, April 5, 2013 12:05 PM

The board of directors of EntreMed, a clinical-stage pharmaceutical company focused on cancer, has appointed two new individuals as directors. Joining the board are James Huang and Y. Alexander Wu, Ph.D.

More... »

ACRP Certification Program - July 31st

MicroConstants China to provide site management services to Chinese hospital

Monday, February 4, 2013 03:39 PM

CRO MicroConstants China, which conducts preclinical pharmacokinetic studies, early-stage clinical trials and regulated bioanalysis in China, has signed a strategic collaboration agreement with the clinical research center of the No. 307 Hospital of People's Liberation Army to provide site management services.

More... »

CRF Health – eCOA Forum

Cytos Biotechnology appoints Itin as CEO

Friday, October 12, 2012 02:29 PM

Cytos Biotechnology, a Swiss biotech company focused on the development of CYT003 in allergic asthma, has appointed Dr. Christian Itin as chief executive officer. The board of directors will propose to the company's shareholders that Itin be elected as member of the board, and it is intended that he will become chairman.

More... »

Theorem names Rosenfeld as vice president

Friday, March 23, 2012 03:28 PM

Theorem Clinical Research, a full-service CRO, has appointed Evan Rosenfeld, M.D., J.D., F.C.L.M., as vice president of medical and scientific affairs, medical device and diagnostics.

More... »

Amgen to Acquire Micromet

Thursday, January 26, 2012 10:53 AM

Amgen, of Thousand Oaks, Calif., will acquire Rockville, Md.-based Micromet for $11 per share in cash, or approximately $1.16 billion. The deal was unanimously approved by both the Amgen and Micromet boards of directors.

More... »

SVTC Technologies partners with SUSS MicroTec

Tuesday, November 15, 2011 01:18 PM

SVTC Technologies, a partner for accelerating nanotechnology development and commercialization, is partnering with SUSS MicroTec, an equipment supplier for MEMS and advanced 3D IC integration. This collaboration is targeted at supporting wafer-level processing for MEMS and 3D IC integration with focus on the newest bonding applications needed for next-generation electronics. The partnership with SUSS MicroTec continues an ongoing SVTC strategy to provide an ecosystem of partners all geared towards providing comprehensive value-added solutions to customers.

More... »

ICR launches clinical research mobile app

Tuesday, August 30, 2011 10:33 AM

The UK-based Institute of Clinical Research (ICR) has launched what it says is a first-of-its kind mobile app for the clinical research community, according to PharmaTimes.

More... »

Covance enters agreement to acquire TRAC Microbiology

Thursday, August 11, 2011 01:35 PM

Covance has entered into a definitive agreement to acquire TRAC Microbiology, a Madison, Wisconsin-based food microbiology and chemistry laboratory. TRAC provides testing, research, auditing, and consulting services to clients ranging from small family businesses to large food-based corporations.

More... »

Pharma industry: Still not budgeting accurately

Monday, August 8, 2011 08:00 AM

Survey shows 57% still relying on Excel spreadsheets

More... »

Micromet collaborates with Amgen

Tuesday, July 12, 2011 10:03 AM

Micromet has entered into a collaboration agreement with Amgen for the research of BiTE antibodies against three undisclosed solid tumor targets. Amgen will have the right to pursue development and commercialization of BiTE antibodies against up to two of these targets, to be selected by Amgen.

More... »

Almac Clinical Services
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

June 17

New CISCRP study finds patient perceptions of trial participation safety, motives greatly improved

PwC: Volume and value of pharma, diagnostics deals soar in first quarter, as CRO sector waits on sidelines

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

June

Operating environment spurs out-of-the-box ideas
High cost, low success rates drive some sponsors to new monitoring, protocol design, patient-centric initiatives

Private equity interest in CROs could lead to more IPOs
Now flush with cash, many PE investors readying to cash out

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

May

INC Research, PPD, inVentiv named top CROs
Yet most CROs slipping in ability to manage site relationships

R&D cuts by sponsors spur more collaboration, innovation
New strategies share pipeline activity costs

Already a subscriber?
Log in to your digital subscription.

Purchase the May issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs